Holen Sie sich die Stockscreener-App
12.13
1.94%
-0.24
Abrdn Life Sciences Investors Aktie (HQL) Neueste Nachrichten
Wells Fargo & Company MN Has $70,000 Position in Abrdn Life Sciences Investors (NYSE:HQL) - Defense World
Wells Fargo & Company MN Sells 5,009 Shares of Abrdn Healthcare Investors (NYSE:HQH) - Defense World
Abrdn Healthcare Opportunities Fund (NYSE:THQ) Stock Price Up 3% – What’s Next? - Defense World
abrdn Healthcare Investors (HQH) Sets $0.54 Monthly Dividend - GuruFocus
abrdn Healthcare Opportunities Fund (THQ) Announces Monthly Divi - GuruFocus
HQL Declares $0.43 Monthly Dividend Yielding 41.92% - GuruFocus
Aberdeen Investments U.S. Closed-End Funds Announce Distribution Payment Details - ACCESS Newswire
Short Interest in Abrdn Life Sciences Investors (NYSE:HQL) Grows By 46.5% - MarketBeat
AQR Arbitrage LLC Has $2.47 Million Stake in Abrdn Life Sciences Investors (NYSE:HQL) - MarketBeat
Abrdn Healthcare Investors (NYSE:HQH) Short Interest Up 26.2% in April - MarketBeat
Abrdn Healthcare Investors (NYSE:HQH) Shares Sold by AQR Arbitrage LLC - MarketBeat
Abrdn Healthcare Investors (NYSE:HQH) Stock Position Increased by Invesco Ltd. - Defense World
Raymond James Financial Inc. Invests $3.13 Million in Abrdn Life Sciences Investors (NYSE:HQL) - MarketBeat
Abrdn Life Sciences Investors (NYSE:HQL) Shares Sold by Quarry LP - MarketBeat
Quarry LP Lowers Holdings in Abrdn Healthcare Investors (NYSE:HQH) - MarketBeat
These 3 Funds Offer Sky-High Yields of 15% or More and Trade at a Discount - Yahoo
Walleye Capital LLC Invests $477,000 in Abrdn Healthcare Investors (NYSE:HQH) - MarketBeat
Press Release Distribution & PR Platform - ACCESS Newswire
abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Healthcare Opportunities Fund (THQ), and abrdn World Healthcare Fund (THW) Announce Investment Team Update - ACCESS Newswire
abrdn U.S. Closed-End Funds Announce Distribution Payment Details - ACCESS Newswire
Short Interest in Abrdn Life Sciences Investors (NYSE:HQL) Increases By 26.3% - MarketBeat
Abrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Saba Capital Management, L.P. Sells 9,144 Shares - MarketBeat
937,656 Shares in Abrdn Healthcare Investors (NYSE:HQH) Purchased by Raymond James Financial Inc. - MarketBeat
Abrdn Healthcare Investors (NYSE:HQH) Short Interest Down 26.0% in March - MarketBeat
Abrdn Healthcare Opportunities Fund (NYSE:THQ) Short Interest Update - Defense World
Abrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Sells $179,718.00 in Stock - MarketBeat
Saba Capital Management, L.P. Sells 30,156 Shares of Abrdn Life Sciences Investors (NYSE:HQL) Stock - MarketBeat
1607 Capital Partners LLC Sells 102,354 Shares of Abrdn Life Sciences Investors (NYSE:HQL) - MarketBeat
Short Interest in Abrdn Healthcare Investors (NYSE:HQH) Declines By 26.0% - Defense World
Saba capital management sells $179,718 in Abrdn life sciences stock - Investing.com Australia
Series CGlycomine - Crunchbase
Glycomine Announces $115 Million Series C Financing to Advance Lead Drug Candidate, GLM101, into a Phase 2b Clinical Trial for PMM2-CDG - Business Wire
LPL Financial LLC Has $3.77 Million Holdings in Abrdn Life Sciences Investors (NYSE:HQL) - MarketBeat
Saba Capital sells $335,937 in abrdn Life Sciences stock - Investing.com Australia
Wilson Sonsini Advises Glycomine on $115 Million Series C - Wilson Sonsini
Saba capital management sells $179,718 in Abrdn life sciences stock By Investing.com - Investing.com South Africa
LPL Financial LLC Raises Holdings in Abrdn Healthcare Investors (NYSE:HQH) - MarketBeat
Saba Capital sells $335,937 in abrdn Life Sciences stock By Investing.com - Investing.com South Africa
0.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):